- Home
- PFIS vs KOD Comparison
PFIS vs KOD Comparison
Compare PFIS & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFIS
- KOD
- Stock Information
- Founded
- PFIS 1905
- KOD 2009
- Country
- PFIS United States
- KOD United States
- Employees
- PFIS N/A
- KOD N/A
- Industry
- PFIS Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PFIS Finance
- KOD Health Care
- Exchange
- PFIS Nasdaq
- KOD Nasdaq
- Market Cap
- PFIS 517.2M
- KOD 454.7M
- IPO Year
- PFIS N/A
- KOD 2018
- Fundamental
- Price
- PFIS $49.25
- KOD $4.45
- Analyst Decision
- PFIS Hold
- KOD Hold
- Analyst Count
- PFIS 1
- KOD 4
- Target Price
- PFIS $47.00
- KOD $8.00
- AVG Volume (30 Days)
- PFIS 23.9K
- KOD 347.2K
- Earning Date
- PFIS 02-06-2025
- KOD 03-27-2025
- Dividend Yield
- PFIS 5.01%
- KOD N/A
- EPS Growth
- PFIS N/A
- KOD N/A
- EPS
- PFIS 0.99
- KOD N/A
- Revenue
- PFIS $115,194,000.00
- KOD N/A
- Revenue This Year
- PFIS N/A
- KOD N/A
- Revenue Next Year
- PFIS $6.61
- KOD N/A
- P/E Ratio
- PFIS $49.75
- KOD N/A
- Revenue Growth
- PFIS 14.83
- KOD N/A
- 52 Week Low
- PFIS $36.26
- KOD $2.19
- 52 Week High
- PFIS $59.70
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- PFIS 40.41
- KOD 27.56
- Support Level
- PFIS $51.06
- KOD $4.85
- Resistance Level
- PFIS $51.94
- KOD $5.53
- Average True Range (ATR)
- PFIS 1.73
- KOD 0.39
- MACD
- PFIS -0.25
- KOD -0.05
- Stochastic Oscillator
- PFIS 0.00
- KOD 1.03
About PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.